Jade Biosciences (JBIO) Institutional Ownership $7.36 +0.59 (+8.71%) As of 08/15/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Jade Biosciences (NASDAQ:JBIO)Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$57.31MNumber ofInstitutional Sellers(last 12 months)0 Get JBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Jade Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data JBIO Institutional Buying and Selling by Quarter Jade Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Corient Private Wealth LLC10,133$101K0.0%N/A1.206% 8/15/2025Soleus Capital Management L.P.796,744$7.96M0.5%N/A94.850% 8/15/2025 Sofinnova Investments Inc.107,391$1.07M0.1%N/A12.785% 8/15/2025 Frazier Life Sciences Management L.P.1,772,116$17.70M0.7%N/A210.966% 8/15/2025 BNP Paribas Financial Markets3,222$32K0.0%N/A0.384% 8/15/2025 Bank of America Corp DE14,350$143K0.0%N/A1.708% 8/14/2025 Orbimed Advisors LLC531,163$5.31M0.1%N/A63.159% 8/14/2025 TCG Crossover Management LLC64,023$640K0.1%N/A7.613% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,757$177K0.0%N/A2.111% 8/14/2025 The Manufacturers Life Insurance Company 11,420$114K0.0%N/A1.358% 8/13/2025 Affinity Asset Advisors LLC65,317$653K0.1%N/A7.776% 8/13/2025 Russell Investments Group Ltd.3,143$31K0.0%N/A0.374% 8/12/2025 XTX Topco Ltd25,752$257K0.0%N/A3.066% 8/12/2025 Ameritas Investment Partners Inc.3,312$33K0.0%N/A0.394% 8/12/2025 Rhumbline Advisers44,570$445K0.0%N/A5.306% 8/12/2025 Legal & General Group Plc2,954$29K0.0%N/A0.352% 8/12/2025 JPMorgan Chase & Co.15,367$154K0.0%N/A1.829% 8/11/2025 Versant Venture Management LLC1,525,820$15.24M18.6%N/A181.429% 8/8/2025 Intech Investment Management LLC22,995$230K0.0%N/A2.734% 8/8/2025 Police & Firemen s Retirement System of New Jersey7,113$71K0.0%N/A0.846% 8/8/2025 Geode Capital Management LLC676,431$6.76M0.0%N/A80.432% 7/18/2025 Deltec Asset Management LLC15,756$157K0.0%N/A1.876% (Data available from 1/1/2016 forward) JBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JBIO shares? During the previous two years, 22 institutional investors and hedge funds held shares of Jade Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($17.70M), Versant Venture Management LLC ($15.24M), Soleus Capital Management L.P. ($7.96M), Geode Capital Management LLC ($6.76M), Orbimed Advisors LLC ($5.31M), Sofinnova Investments Inc. ($1.07M), and Affinity Asset Advisors LLC ($653K).Learn more on Jade Biosciences' institutional investors. Which institutional investors have been buying Jade Biosciences' stock? Of the 22 institutional investors that purchased Jade Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.77M), Versant Venture Management LLC ($1.53M), Soleus Capital Management L.P. ($796.74K), Geode Capital Management LLC ($676.43K), Orbimed Advisors LLC ($531.16K), Sofinnova Investments Inc. ($107.39K), and Affinity Asset Advisors LLC ($65.32K). How much institutional buying is happening at Jade Biosciences? Institutional investors have bought a total of 5,736,849 shares in the last 24 months. This purchase volume represents approximately $57.31M in transactions. Related Companies CASI Pharmaceuticals Institutional Ownership Aytu BioPharma Institutional Ownership Q32 Bio Institutional Ownership Promis Neurosciences Institutional Ownership Natural Alternatives International Institutional Ownership Lisata Therapeutics Institutional Ownership Rallybio Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Elevation Oncology Institutional Ownership Dare Bioscience Institutional Ownership This page (NASDAQ:JBIO) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access